Hem › Triplenegativ bröstcancer › Indiana › Indianapolis
Kliniska studier för Triplenegativ bröstcancer i Indianapolis, IN
9 studier för Triplenegativ bröstcancer söker deltagare vid platser i och runt Indianapolis (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekryterarFas 1
- IU Simon Cancer Center, Indianapolis
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekryterarFas 3
- Franciscan Health ( Site 0077), Indianapolis
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
RekryterarFas 3
- Franciscan Health Indianapolis, Indianapolis
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
RekryterarFas 2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
A Study of LY4175408 in Participants With Advanced Cancer
RekryterarFas 1
- Community Health Network, Indianapolis
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekryterarFas 1
- Community Health Network, Inc. /ID# 243011, Indianapolis
A Study of Tetrathiomolybdate (TM) Plus Capecitabine
RekryterarFas 1/2
- Indiana University Simon Cancer Center, Indianapolis
NearWave Optical Molecular Monitoring
Rekryterar
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
RekryterarFas 1/2
- Community Health Network, Indianapolis
Triplenegativ bröstcancer-studier i andra städer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andra studier i Indianapolis
- Icke-småcellig lungcancer32 studier
- Cancer (alla typer)24 studier
- Hjärtsvikt23 studier
- Övervikt20 studier
- Bröstcancer20 studier
- Metastaserande cancer19 studier
- Kolorektal cancer18 studier
- Äggstockscancer17 studier
- Hjärt-kärlsjukdom17 studier
- Lungcancer16 studier
- Typ 1-diabetes14 studier
- Endometriecancer14 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.